Immunotherapy
News and reporting on cancer immunotherapy.
The iMMagine-1 data suggest anito-cel could have a differentiated safety and efficacy profile compared to available BCMA-directed therapies.
The data suggest that multiple myeloma patients on Janssen's CAR T-cell therapy lived longer than on BMS's but experienced more severe side effects.
'Fresh-In, Fresh-Out' Dual-Targeted CAR T-Cell Therapy Shows Promise in Phase II DLBCL Trial
Premium
The non-cryopreserved CD19- and CD20-directed CAR T-cell therapy zamto-cel is manufactured in a closed-system device that could enable point-of-care treatment.
Epsilogen Launches Phase Ib IgE Antibody Trial in Advanced Ovarian Cancer
In the study, the firm will enroll previously treated patients whose tumors are positive for FRα based on IHC testing.
Merck, Moderna Vax Trial Starts Enrolling Lung Cancer Patients at McGill University Health Center
The trials are evaluating an individualized neoantigen vaccine with Keytruda as an adjuvant therapy for non-small cell lung cancer.